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Essential role of the TFIID subunit TAF4 in murine
embryogenesis and embryonic stem cell
differentiation
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Gabrielle Mengus1 & Irwin Davidson1
TAF4 (TATA-binding protein-associated factor 4) and its paralogue TAF4b are components
of the TFIID core module. We inactivated the murine Taf4a gene to address Taf4 function
during embryogenesis. Here we show that Taf4a / embryos survive until E9.5 where
primary germ layers and many embryonic structures are identiﬁed showing Taf4 is
dispensable for their speciﬁcation. In contrast, Taf4 is required for correct patterning of the
trunk and anterior structures, ventral morphogenesis and proper heart positioning.
Overlapping expression of Taf4a and Taf4b during embryogenesis suggests their redundancy
at early stages. In agreement with this, Taf4a / embryonic stem cells (ESCs) are viable and
comprise Taf4b-containing TFIID. Nevertheless, Taf4a / ESCs do not complete
differentiation into glutamatergic neurons and cardiomyocytes in vitro due to impaired
preinitiation complex formation at the promoters of critical differentiation genes. We deﬁne
an essential role of a core TFIID TAF in differentiation events during mammalian
embryogenesis.
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F
ormation of the RNA polymerase II (Pol II) preinitiation
complex (PIC) requires a set of general transcription factors
among which is TFIID, a multiprotein complex composed
of the TATA-binding protein (TBP) and a set of TBP-associated
factors (TAFs)1. TFIID assembles from a ‘core complex’
comprising TAF4, TAF5, TAF6, TAF9 and TAF12, followed by
TAF8-TAF10, and then association with a second module
comprising TBP, TAF1, TAF2 and TAF7 (refs 2,3). In
mammals, core TAFs are almost ubiquitously expressed,
although cell-speciﬁcally expressed paralogues of TBP and a
subset of TAFs have been described and their functions deﬁned
by mouse knockouts. Taf7l plays a critical role in male germ cell
development and in adipocytes4–6, Taf4b is essential for male and
female fertility7,8 and Taf9b regulates neuronal gene expression9.
Trf2 and Trf3, the two TBP paralogues, play essential roles in the
male and female germ lines, respectively10,11.
TAF4 forms a histone fold heterodimer with TAF12 (refs 12–14)
that associates with the TAF6–TAF9 heterodimer and TAF5 to
form the TFIID core module. TAF4 is crucial for the structural
integrity of the core module and TFIID1,15. Its paralogue TAF4B
also heterodimerizes with TAF12 and integrates into TFIID, thus
maintaining TFIID integrity in the absence of TAF4 (ref. 16).
While we have used somatic inactivation to address the function of
murine Taf4 in mouse embryonic ﬁbroblasts (MEFs), the adult
murine epidermis or neonatal liver16–19, its role in embryogenesis
is unknown.
Here we characterise Taf4a / (gene encoding Taf4) embryos
showing they survive until E9.5, but exhibit severe growth
retardation and speciﬁc defects in anterior and ventral patterning
and morphogenesis. We also show that Taf4a / embryonic
stem cells (ESCs) are viable, but are unable to properly
differentiate into glutamatergic neurons and cardiomyocytes
in vitro due to impaired PIC formation at the promoters of
critical differentiation genes. Thus, while Taf4b can compensate
for the absence of Taf4 during the early stages of embryogenesis
and in ESCs, Taf4 plays speciﬁc roles in differentiation in vivo
and in vitro.
Results
Mid-gestation embryonic lethality of Taf4a / embryos. Mice
with ﬂoxed and null Taf4a alleles16 (Taf4alox/ and Taf4aþ / )
were viable, fertile and did not exhibit any apparent
abnormalities. Breeding of Taf4aþ / mice did not yield any
Taf4a / pups, indicating death in utero16. We, therefore,
analysed embryogenesis at various developmental stages after
crosses of Taf4aþ / animals.
Taf4a / embryos could be distinguished from Taf4aþ /þ
and Taf4aþ / embryos by their smaller overall size at E6.5
(Fig. 1a–c). By E7.5 mutant embryos displayed a more compact
appearance (Fig. 1d–g), and by E8.5, a shortened body axis and
under-developed head and trunk regions (Fig. 1h–k). Between
E8.5 and E9.5, mutant embryos showed virtually no increase in
overall size, but developmental processes continued with for
example formation of a primitive heart. Nevertheless, the overall
morphology of Taf4a / embryos showed that their develop-
ment did not proceed much beyond that of E8.5 wild-type (WT)
embryos (Fig. 1k–m and see below). At E9.5, mutant embryos
were severely growth retarded and subsequently resorbed
(Fig. 1l–o). Genotyping indicated that Taf4a / embryos were
present in approximately Mendelian ratios until E9.5 after which
time they died and were longer detected (Supplementary Table 1).
Histology analysis showed that WT E7.5 embryos had completed
division of the proamniotic cavity into the exocoelomic and the
amniotic cavities, separated by the amniotic membrane (Fig. 1r),
whereas in Taf4a / embryos this compartmentalization had not
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Figure 1 | Taf4 is required during mid-gestation. (a–c) E6.5 stage embryos
of the indicated genotypes. (d–g). E7.5-stage embryos of the indicated
genotypes, g shows a blow up of f. Scale bar, 100mm. (h–k). E8.5-stage
embryos of the indicated genotypes, k shows a blow up of j. (l–o) E9.5-
stage embryos of the indicated genotypes, o shows a blow up of n. Scale
bar, 200mm. (p–u) Haematoxylin and eosin-stained sections through WTor
mutant embryos at the indicated stages. Scale bar, 100mm. ep,
ectoplacental cone; ve, visceral endoderm; ee, embryonic ectoderm; me,
mesoderm;, epc, ectoplacental cavity; ch, chorion; ex, exocoelomic cavity;
am, amnion; ac, amniotic cavity; hf, headfold; ht, heart; fg, foregut; hg,
hindgut; so, somites; vys, visceral yolk sac; ps, primitive streak.
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occurred resulting in an open proamniotic cavity (Fig. 1s).
Taf4a / embryos showed reduced size and overall resembled
WT embryos at the egg cylinder stage at E6.5 (Fig. 1p,q). WT E8.5
embryos underwent major developmental events, including foregut
invagination, concurrent headfold and heart tube development, and
formation of the ﬁrst somite pairs (Fig. 1t). In contrast, Taf4a /
embryos displayed severely under-developed anterior structures
with no apparent heart structure formation or foregut invagination.
Headfold-like mesenchymal tissues were compact, showed poor
morphogenesis and reduced size. A large section of the trunk region
was missing and somites were small, compact and tightly spaced
(Fig. 1u and see below Fig. 3). At E8.5 the developing amniotic
structure appeared agglutinated and failed to elongate properly to
surround the embryo.
Taf4a / embryos showed growth defects at E6.5 and most
severe by E9.5. To examine this, we measured 5-bromo-2’-
deoxyuridine (BrdU) incorporation, but no major change in
proliferation rates was seen (Supplementary Fig. 1A). In contrast,
we observed increased apoptosis in mutant embryos assessed by
terminal deoxynucleotidyl nick-end labelling on whole-mount
embryos and parafﬁn sections (Supplementary Fig. 1B,C).
Increased apoptosis occurring as early as E7.5, rather than
reduced cell proliferation, therefore contributes to the smaller size
of the Taf4a / embryos.
Overlapping embryonic expression of Taf4a and Taf4b. Whole-
mount in situ hybridization indicated ubiquitous expression of
Taf4a (Supplementary Fig. 2A). A speciﬁc signal was observed
with the anti-sense probe throughout the embryo and the
extraembryonic region at E6.5 and E7.5. By E8.5, Taf4a mRNA
was detected in the entire embryo and in the yolk sac. Consistent
with the in situ hybridization, Taf4 protein was detected
throughout the E7.5 WT embryo, but was absent from the mutant
embryos (Supplementary Fig. 2B).
As Taf4a / embryos die much later than germ line
knockouts for Tbp or other core Tafs, it is possible that Taf4b
may at least partially compensate for Taf4 loss. In situ
hybridization showed ubiquitous Taf4b expression at E6.5 that
was more pronounced in the extraembryonic region
(Supplementary Fig. 2A). At E7.5 Taf4b was expressed through-
out the epiblast and extraembryonic regions. Notably, however,
expression in the visceral endoderm and the deﬁnitive endoder-
mal layer was weaker than Taf4a. Distinct enrichment in Taf4b
expression in regions corresponding to the ectoplacental cavity
and in a ring of extraembryonic ectoderm at the mid proximo-
distal domain was observed. At E8.5 Taf4b expression closely
resembled that of Taf4a, with the exception of the yolk sac where
staining was weaker than Taf4a.
The overlapping expression suggests Taf4b may partially
compensate for lack of Taf4a and thus account for the later
death of Taf4a mutants. Indeed, Taf4b expression was detected
throughout the Taf4a mutant embryos at E8.5 (Supplementary
Fig. 2C). Quantitative reverse transcription–PCR (RTq–PCR)
analysis conﬁrmed that its expression was virtually unchanged in
the mutant embryos (Supplementary Fig. 2D). All other TFIID
Tafs were comparably expressed in WT and mutant embryos.
Only Taf5, Taf6 and Taf13 showed42-fold increased expression
in the mutant embryos (Supplementary Fig. 2D).
Defective heart formation in Taf4a / embryos. The yolk sac
comprises a bilayer structure of mesoderm- and endoderm-
derived cells crucial for embryo survival. The ﬁrst blood cells and
blood islands develop in the mesodermal compartment of the
yolk sac20–22. Before E8.5 mouse embryos are in a lordotic
position such that the embryo initially faces the outside of the egg
cylinder (ref. 23 and Fig. 2a). Around E8.5 the embryo rotates
around its own axis placing the heart in a ventral position
(Fig. 2a,b) and the amnion enlarges to surround the whole
embryo. The exocoelome lining consisting of visceral endoderm
and mesoderm also expands and eventually surrounds the whole
embryo as the visceral yolk sac.
Taf4a / embryos failed to turn by E9.5 developing partially
outside the yolk sac that was reduced compared with WT
(Fig. 2c–f). Mutant embryos lacked the blood-ﬁlled vascular
plexus and the developing blood vessels seen in WT yolk sacks,
suggesting defective erythroid cell generation (Fig. 2c–f). In
mutant yolk sacks, endothelial cells were present, but did not
form organized vascular structures (Supplementary Fig. 3A).
Immunolabeling with PECAM-1, an endothelial cell-speciﬁc
maker, revealed formation of a primitive vascular system only
on the dorsal surface of the Taf4a / embryos adjacent to the
neural tube that failed to pervade the interior of the embryo
(Supplementary Fig. 3A). Defective allantois fusion to the
chorionic plate was also observed. At E9.5, fusion is complete
in 100% of the WT embryos, compared with only 10% of mutant
embryos (Fig. 2k,l and Table 1).
E9.5 WT embryos displayed a well-organized heart tube with
erythrocytes visible in the inﬂow region (Fig. 2d), whereas mutant
embryos showed primitive cardiac structures bulging from the
headfold base often developing outside the amnion in the
exocoelomic cavity (Fig. 2g–i and Table 1). In rare cases, heart
structures developed outside the visceral yolk sac (Fig. 2j–l).
While 100% of WT embryos developed a primitive heart tube by
E8.5, only 8% of mutant embryos showed a small bulge indicating
a severely retarded initiation of heart tube formation (Fig. 2g–l
and Table 1). At E9.5 all WT hearts showed contractions on
dissection, whereas this was never observed in mutant embryos.
In situ hybridization showed specﬁc expression of cardiac
transcription factor Nkx2–5 in the prospective myocardium of
the atria, ventricles, and outﬂow tract in E8.5 WT embryos
(Fig. 2m,o). In contrast, mutant embryos exhibited a crescent-like
expression domain with no evident heart chamber formation
indicating that although cardiac lineage speciﬁcation occured,
heart tube morphogenesis was defective (Fig. 2n,p). Expression of
a second cardiac transcription factor Tbx5 was similar to Nkx2–5
although this factor was expressed at higher levels in inﬂow tract
Table 1 | Quantiﬁcation of observed phenotypes in Taf4a / embryos.
Gestational age Cardiac defects Other defects
No Heart Heart in
amniotic
cavity
Heart in
exocoelmic
cavity
Heart
outside
visceral yolk
sac
Allantois not
fused
Embryo not turned
E8.5 22/24 (92%) ND ND ND NA NA
E9.5 18/66 (27%) 1/25 (4%) 21/25 (84%) 3/25 (12%) 19/21 (90%) 66/66 (100%)
ND, not determined; NA, not applicable
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structures and showed additional staining in the prospective
forelimb ﬁeld (Fig. 2q,s). In mutant embryos, Tbx5 showed a
crescent-like expression domain, with no expression in the
prospective forelimb (Fig. 2r,t). These crescent-like domains in
the E8.5 mutant embryos closely resembled the expression
pattern of heart-speciﬁc markers in the cardiac crescent of E7.5
WT embryos. Importantly however, histology analyses and in situ
hybridization indicated mis-localization of the primitive heart
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Figure 2 | Taf4 is required for correct positioning of head and heart. (a,b). Schematic representations illustrate normal development at E8.5 and E9.5
highlighting positions of head and heart during embryo turning. (c–f) WT and mutant embryos at E9.5 before and after dissection from the yolk sac
highlighting the blood-ﬁlled yolk sac vascular plexus in control embryos (red arrow in c) and the embryo protruding partially out of the yolk sac (green
arrow in e). WT embryos show a strong accumulation of blood in the atrium of the heart (red arrow in d), which was absent in Taf4a / embryos (f).
(g–i) Schematic illustration of observed mutant phenotypes at E9.5. All mutant embryos fail to undergo turning at E9.5 and fusion of the allantois to the
chorion. In addition to this, mutant embryos develop heart structures either in the exocoelomic cavity (h–i) or outside of the visceral yolk sac (k–l).
(m–w) In situ hybridization of wild-type and Taf4a / embryos for the cardiac transcription factors Nkx2-5 at E8.5 (m–p) or Tbx5 at E8.5 (q–t) and E9.5
(u–w). ep, ectoplacental cone; all, allantois; ht, heart; ﬂp, forelimb precursors; ift, inﬂow tract. Scale bar, 500mm (c–f), 300mm (h-i), 200mm (m–w).
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structures anterior to the headfolds rather than in the ventral
position in keeping with the absence of turning of the mutant
embryos. This was highlighted by in situ hybridization with
Nkx2–5 at E9.5 labelling the developing heart structure at the
anterior pole of the embryo next to the headfolds rather than in a
ventral position as in WT (Fig. 2u–w). Taf4a / embryos
therefore display defective cardiac development that, together
with lack of chorio-allantoic fusion and defective yolk sac and
intra-embryonic vascularization, likely accounts for embryonic
death at mid-gestation.
Abnormal anterior patterning of Taf4a / embryos. We next
used speciﬁc markers to investigate defective anterior develop-
ment of Taf4a / embryos, The anterior visceral endoderm
(AVE) regulates initial steps of head, heart and foregut
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Figure 3 | Abnormal patterning of Taf4a / embryos. (a–o) (upper row). In situ hybridization with the indicated probes for anterior visceral endoderm
(AVE) and mesoderm markers on E7.5 WTembryos. (b–p) (lower row). In situ hybridization with the indicated probes on E7.5 Taf4 / embryos. (q–ao).
In situ hybridization with neuronal markers in E9.5 WTor Taf4 / embryos (lateral views (q–ak); ventral view R dorsal views T-AN) and (lateral views RP-
AL, higher magniﬁcations of same embryos s–am; ventral view U; dorsal views z–ao). Scale bar, 200mm in all panels.
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positioning. Defective expression of AVE markers leads to severe
anterior truncation phenotypes24. Expression domains of several
AVE markers in E7.5 Taf4a / embryos were either reduced
(Hesx1, Hex and Dkk1) or showed retarded formation (Foxa2,
Otx2, Fig. 3a–l). In contrast, expression domains of mesodermal
markers Brachyury (T) and Cripto were comparable in WT and
mutant embryos (Fig. 3m–p).
To investigate differentiation of speciﬁc anterior structures, we
studied expression of forebrain, midbrain and hindbrain
markers. Otx2 is required for induction and maintenance of the
anterior neural plate25,26 and speciﬁcation of forebrain and
midbrain regions. The Otx2 expression domain was diminished
in E9.5 Taf4a / mutants, particularly the forebrain was
strongly reduced (Fig. 3q–u). Pax2 was expressed in the
developing midbrain–hindbrain region, the otic vesicle, and the
mesonephros in WT embryos, whereas in mutant embryos
midbrain–hindbrain staining was reduced, and the presence of
nephrogenic precursor cells was observed. In contrast, no
staining of presumptive otic vesicle structures was observed
(Fig. 3v–z).
In WT E9.5 embryos, Krox20 marked rhombomeres 3 and 5.
In mutant embryos, labelled structures were thinner and
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Figure 4 | Neural crest cell markers and primordial germ cells in Taf4 mutant embryos. (a–o) In situ hybridizations for neural crest markers Sox10, Crabp1
andWnt1 in E9.5 control (lateral views a,f,k dorsal views d,i,n) and Taf4a / embryos (lateral views b,g,l higher magniﬁcations of the same embryos c,h,m
dorsal views E, J, O ). (p–u). In situ hybridizations at E9.5 with Pou5f1 (Oct4) as a marker for primordial germ cells (PGCs). ba1, ﬁrst branchial arch; ba2,
second branchial arch; ov, otic vesicle; cncc, cranial neural crest cells; mhb, midbrain–hindbrain boundary; nt, neural tube. Scale bar, 200mm in all panels.
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disorganized with rhombomere 5 more affected than rhombo-
mere 3 (Fig. 3aa–ae). Hoxb1, a marker for rhombomere 4, was
clearly detected in mutant embryos (Fig. 3af–aj), whereas Mafb
(Kreisler), expressed in rhombomeres 5 and 6 in WT embryos
(Fig. 3ak,an), stained only a single stripe in Taf4a / mutants
(Fig. 3al,am,ao), which in some instances, was thinner than the
Hoxb1-positive stripe (compare Fig. 3ag,al). Thus, although the
anterior region of mutant embryos was severely atrophied, this
did not reﬂect a complete lack of forebrain/midbrain/hindbrain
speciﬁcation, all of which were present albeit both reduced in size
and disorganized. Uncx staining showed fewer (typically 8–11)
and irregularly shaped somites in E9.5 Taf4a / mutants.
The above analyses revealed an immediate proximity of the
hindbrain and somite markers (Uncx) and a reduction or absence
of the hindbrain posterior to rhombomere 5 along with a
signiﬁcant portion of the trunk. We analysed the anterior–
posterior axis and gut development in mutant embryos.
Foxa2 and Shh labelled the notochord and developing hindgut
in E9.5 WT embryos, but only one structure in mutant
embryos (Supplementary Fig. 3B). Brachyury (T) staining
indicated the labelled structure was the notochord
showing interruption at one or several places, perhaps due to
local apoptosis or tissue distortion (Supplementary Fig. 3C).
The notochord showed stronger anterior staining by Brachyury
and Foxa2 indicating defective elongation along the
anterior–posterior axis. Nevertheless, mutant embryos main-
tained strong Brachyury staining in their posterior region,
which was proportionally larger than in WT embryos at E8.5
and E9.5. This could indicate a defect in speciﬁcation and
differentiation of axial mesendodermal structures. Taf4a /
embryos therefore fail to develop a detectable gut tube consistent
with histology analysis that showed lack of a foregut pocket E8.5
(Fig. 1u) and their shortened notochord is consistent with the
absence of an elongated trunk region.
Reduced neural crest domain in Taf4a / embryos. Having
deﬁned defective anterior and trunk development, we next
investigated neural crest cells (NCCs) normally induced at the
midbrain level and as a wave extending towards the tail region.
Defects in NCCs may contribute to the defects observed in the
cephalic and trunk region of the Taf4a / embryos.
In E9.5 WT embryos, Crabp1 labelled the neural tube and
NCCs originating in the posterior hindbrain and anterior trunk
regions that give rise to cranial NCCs migrating into the
branchial arches and posterior regions (Fig. 4a,d). A severely
reduced Crabp1 expression domain was seen in mutant embryos,
indicating they were completely devoid of migrating NCCs in
both the cranial and posterior regions (Fig. 4b,c,e). The residual
y-shaped expression domain may correspond to part of the neural
tube and primitive branchial arch 1. Similarly, Sox10, a marker
with more restricted expression domains in the otic vesicle and
the NCCs migrating into the branchial arches (Fig. 4f,i), also
showed severely reduced expression in the mutant embryo and no
migrating NCCs were observed (Fig. 4g,h,j). Furthermore, Wnt1
expression was absent from the spinal cord and NCCs
(Fig. 4k–o). Taf4a / embryos therefore lack a large portion
of the NCCs migrating towards craniofacial structures and more
posterior trunk regions.
Taf4 is dispensible for primordial germ cell generation. Given
the role of Taf4 in reprogramming (ref. 27 and see below), we
speciﬁcally investigated the presence of primordial germ cells
(PGCs) in Taf4a / embryos. PGCs colonize the developing
gonads by migration giving rise to oocytes and spermatocytes in
adults28. PGCs can be identiﬁed at around E7.25 (refs 29,30) and
begin to migrate through the primitive streak to the developing
hindgut, and by EE9.5 towards the genital ridges. Mutant
embryos lack a properly developed hindgut mesentery at E9.5.
We investigated whether mutants were able to initiate PGC
development. At E7.5 Pou5f1 (Oct4) is exclusively expressed by
the newly formed PGCs, and expression persists as they migrate
and proliferate. We readily detected Pou5f1-expressing PGCs in
the WT hindgut mesentery at E9.5 (Fig. 4p–r). In mutant
embryos, Pou5f1-expressing PGCs could be observed, but were
around 10-fold less numerous than in WT (Fig. 4s–u). These
PGCs accumulated at the presumptive entry site into the hindgut
lacking in mutant embryos. Thus, PCG speciﬁcation takes place
in absence of Taf4, but they cannot migrate and pursue their
proliferation due to the absence of the hindgut.
Taf4a / ESCs are viable and comprise TFIID containing Taf4b.
The lethality, reduced size and pleiotropic defects of the Taf4a /
embryos preclude biochemical and functional analysis of speciﬁc
differentiation events. Nevertheless, as death occured at mid-gesta-
tion, it should be possible to derive Taf4a / ESCs and use them to
address the role of Taf4 in speciﬁc differentiation programmes. We
isolated ESCs from blastocysts of Taf4aþ / heterozygous crosses
and established two homozygous null lines and two WT lines from
these crosses. The absence of Taf4 protein in Taf4a / ESCs was
conﬁrmed by immunostaining, while pluripotency markers Pou5f1,
Nanog and Sox2 were normally expressed (Supplementary Fig. 4A–
C). WT and Taf4a / ESCs showed comparable alkaline phos-
phatase staining, proliferation rates and cell cycle proﬁles
(Supplementary Fig 4D–F). Comparative RNA sequencing (RNA-
seq) revealed only minor differences in gene expression. Around 40
genes were upregulated although only 12 showed more than a
threefold change, whereas 166 genes were downregulated
(Supplementary Fig. 4G) including Noggin and several genes asso-
ciated with Wnt signalling. However, their altered expression did not
elicit detectable changes in cell physiology and no change in plur-
ipotency gene expression was observed. Together these data show
that Taf4a / ESCs are viable and comparable in most essential
parameters to WT ESCs.
To characterise ESC TFIID and to compare it with
human ESCs and MEFs, we performed western blot analysis.
WT mouse ESCs express Tbp and all tested Tafs, including Taf4b.
For equivalent amounts of protein extract, expression of
many Tafs was higher in ESCs than in MEFs (Fig. 5a), consistent
with previous reports27. In two human ESC lines, no expression
of TAF1, TAF4 and TAF5 was seen, although TAF4b was
detected. These observations conﬁrm previous reports of non-
canonical TFIID composition in human ESCs31, and highlight
fundamental differences in the biochemistry of mouse and
human ESCs.
Comparison of WT and Taf4a / ESCs indicated comparable
expression of most TAFs. Tbp was immunoprecipitated (IP) from
both lines and equivalent amounts of Tbp loaded on immuno-
blots (Supplementary Fig. 5). Taf4b was co-precipitated with Tbp
in both the presence and absence of Taf4 indicating that Taf4b
maintained TFIID integrity in Taf4a / ESCs. Nevertheless,
reduced levels of several TAFs, with respect to Tbp, were observed
in the Tbp IP from the Taf4a / ESCs suggesting that Taf4b
expression was not sufﬁcient to maintain an overall TFIID level
comparable to WT ESCs.
We then performed gel ﬁltration and analysed the presence of
Tbp and TAFs in the high-molecular mass fractions. Tbp and
TAFs coeluted in a high molecular mass complex of around
2mDa in WT extracts (Fig. 5b). Taf4b was also present in these
fractions, although a subfraction eluted in a lower molecular mass
complex. In Taf4a / extracts, Taf4b was present along with
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Tbp and other tested TAFs in high-molecular mass fractions,
although Tbp and many TAFs were present in reduced amounts
in particular Taf7 and Taf10 that were increased in lower
molecular weight fractions.
To investigate whether the high-molecular mass fractions
correspond to TFIID, the indicated fractions were pooled and
subjected to Tbp IP. In fractions from WT and mutant ESCs, Tafs
1, 4b, 6, 7, 10, 12 and 13 were co-precipitated with Tbp showing
formation of a TFIID complex in both cell types (Fig. 5c). In
fractions from WT cells, both Taf4 and Taf4b were precipitated,
while in the fractions from mutant cells only Taf4b was present.
Taf4b therefore integrates in TFIID in Taf4a / ESCs, but these
cells contain lower overall levels of TFIID as the presence of
Taf4b cannot quantitatively compensate Taf4 loss.
To further verify potential redundancy between Taf4 and
Taf4b, we transfected WT and Taf4a / ESCs with control
small interfering RNA (siRNA) and siRNAs directed against
Taf4b. After control siRNA and siTaf4b silencing in WT ESCs
and replating the transfected cells, comparable numbers of
alkaline phosphatase staining colonies were observed expressing
comparable levels of Nanog, showing that Taf4b knockdown did
not compromise cell viability (Supplementary Fig. 6A–C). In
contrast, Taf4b silencing in Taf4a / ESCs led to a strong
reduction in the number of colonies and surviving cells showed
normal Taf4b and Nanog expression. Hence, Taf4b silencing in
Taf4a / ESCs strongly compromised cell viability and only
cells that had escaped transfection formed colonies. These results
indicate that ESCs lacking either Taf4 of Taf4b were viable. In
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contrast, loss of both proteins through genetic deletion of Taf4
and subsequent Taf4b silencing resulted in a loss of viability. Taf4
and Taf4b are therefore redundant in terms of assuring cell ESC
viability.
Defective neuronal differentiation of Taf4a / ES cells.
Taf4a / ESCs were grown as embryoid bodies (EBs) to
determine their spontaneous differentiation capacity over a per-
iod of 14 days. Taf4a / EBs initially appeared indistinguishable
from WT EBs, but at later stages, gave rise to fewer cystic-like
structures (Supplementary Fig. 7A) that resemble the developing
yolk sac in vivo32. Hence, in vitro differentiated Taf4a / ES
cells recapitulated to some extent the phenotype of the Taf4a /
embryos. Taf4 was expressed throughout WT EB differentiation,
while Taf4b expression was strongly decreased, but Taf4b was
maintained in the mutant cells (Supplementary Fig. 7B).
We investigated whether Taf4a / ESCs could give rise to the
three primary germ layers. Expression of the pluripotency
markers Nanog and Dppa3 was reduced, but incompletely
repressed compared with WT (Supplementary Fig. 7B). The
early endoderm and mesoderm markers Gata4 and Gata6 were
induced, whereas late endodermal lineage markers like Foxa2,
and Afp were strongly downregulated (Supplementary Fig. 7B).
Mesendodermal markers Brachyury (T) and Goosecoid (Gsc)
showed a strong upregulation in day 6 EBs before their expression
returned to normal levels, indicating that Taf4 may regulate the
ﬁne-tuning of their expression. Expression of the early cardiac
marker Nkx2–5 and its downstream target gene Anf was also
reduced. Taf4a / ESCs can therefore initiate differentiation
into early mesoendodermal-type cells, whereas later stage
differentiation markers were more strongly affected.
Expression of the early ectodermal marker Fgf5 was induced,
but expression of later neuronal markers such as Pax6 and Mtap2
and Dcx was strongly reduced (Supplementary Fig. 7B). To
investigate the role of Taf4 in neuronal differentiation, we
differentiated WT and Taf4a / ESCs into glutamatergic
neurons by treating EBs with all-trans retinoic acid (RA)
(Supplementary Fig. 8A, refs 33,34). Expression of the vesicular
glutamate transporter Vglut2 as well as Taf4 was observed in such
neurons cultured for 12 days (Supplementary Fig. 8B).
Dissociated RA-treated WT EBs differentiated into neuronal
precursors shortly after plating and adopted neuronal morphol-
ogy with abundant axons and prominent Tubb3 staining after 2
days (Fig. 6a,b). In contrast, mutant EBs failed to generate
neuronal precursors with an axonal network and most cells died
within a day. After 1–2 days, the few remaining cells appeared
ﬂattened and enlarged. Western blot showed only weak Tubb3
expression in mutant cells, but also revealed defective repression
of Pou5f1 and Nanog whose expression was strongly repressed
after differentiation of WT EBs (Fig. 6c). Taf4 is therefore
essential for RA-induced neuronal differentiation and for
pluripotency gene repression.
Immunoblot analysis showed a mild overall reduction in Tbp
and Taf expression by day 8 of WT EB differentiation (Fig. 6d).
On differentiation of mutant EBs, the overall reduction in Taf
levels was less marked with no decreased Taf4b expression,
whereas Taf3 and Taf5 were reduced.
To demonstrate that defective differentiation was due to Taf4
loss, we generated Taf4a / ESCs stably re-expressing exogen-
ous full-length Taf4 (Fig. 6e). WT ESCs isolated in parallel after
transfection with control vector showed normal neuronal
differentiation with an abundant Tubb3-stained axonal network,
whereas the Taf4a / EBs transfected with control vector
showed no neuronal differentiation (Fig. 6f). Importantly, the
rescue Taf4a / line showed comparable differentiation to the
WT lines. Defective differentiation was therefore directly
attributable to Taf4 loss and restored by its re-expression. We
also attempted to rescue differentiation by the expression of Taf4
(372–1,083) and Taf4 (805–1,083); however, no stable clones
could be isolated suggesting that expression of truncated Taf4 was
toxic in these cells. The integrity of Taf4 is therefore required to
rescue the differentiation defects.
We performed RNA-seq on two independent WT and mutant
ESC lines before (EB4) and 24 (EB5) and 96 h (EB8) after RA
treatment. At EB4 585 deregulated genes were observed (354
down and 231 up, Fig. 7a). Similarly, at EB5, 255 upregulated and
287 downregulated genes were detected, but the highest number
of deregulated genes was observed at EB8 (1,212 up and 1,008
down). Thus, Taf4b can replace Taf4 to maintain cellular
housekeeping functions and pluripotency and to a limited extent
the initial stages of differentiation, but Taf4 is required for full
differentiation with progressively more severe alterations in gene
expression as differentiation progressed (Fig. 7a).
At EB8, genes involved in neurogenesis are strongly down-
regulated, whereas many pluripotency genes are prominent in the
upregulated class (Fig. 7b,c). Downregulated genes are highly
associated with the brain, while upregulated genes are associated
with ESCs and spermatogenesis reﬂecting the presence of stem-
like genes expressed in PGCs and spermatogonia (Supplementary
Fig. 8C). Clustering identiﬁed genes with distinct kinetics of
expression in WT cells and altered expression in Taf4a / cells.
Three clusters show the most prominent changes. Genes in
cluster 2 were upregulated when WT ES cells were grown as EBs,
but were most strongly induced after RA treatment at EB5 and
were highly enriched in brain and neurogenesis functions
(Fig. 7d). In mutant ESCs, their activation was strongly reduced
whereby expression at EB8 was comparable to that of WT EB4.
Genes in cluster 3 were also strongly enriched in brain and
neurogenesis, but were mainly activated between EB5 and EB8
and were strongly reduced in mutant cells. In contrast, genes in
cluster 4 are ES-expressed and pluripotency genes downregulated
in WT EBs, then switched off during their differentiation,
whereas in Taf4a / EBs, their expression persisted during
differentiation.
Similar to Taf4a / cells in vitro, expression of several
neuronal genes was downregulated in Taf4a / embryos
showing that Taf4 is also required for their normal expression
in vivo (Supplementary Fig. 8D). Expression of Pou5f1, and
Nanog was, however, repressed in Taf4a / embryos, but that of
other pluripotency associated genes like Zfp42 and Dppa5a
remained elevated at E9.5.
The above data show that WT ESCs differentiated into
neuronal precursors that switched off pluripotency gene expres-
sion, whereas Taf4a / ESCs adopt a unique state with partially
induced expression of differentiation genes, and partially
repressed expression of pluripotency genes.
Defective PIC formation at neuronal genes. The above classi-
ﬁcation based on kinetics of gene expression also reﬂects different
regulatory mechanisms as revealed by ChIP-seq. TFIIB, Pol II,
H3K4me3 and H3K27ac were present at promoters of genes in
cluster 1 in WT ESCs. Consistent with increased expression of
these genes during differentiation, TFIIB, Pol II and H3K27ac
were increased at EB8 (Fig. 7e). In contrast, lower occupancy was
seen in Taf4a / ESCs and little change was observed at EB8 in
accordance with their reduced activation. TFIIB, Pol II, H3K4me3
and low levels of H3K27ac were observed at cluster 2 promoters
in WT and mutant ESCs and activation of these genes was
associated with increased occupancy in WT EB8, but not in
Taf4a / EB8. Increased elongating Pol II was also observed in
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms11063 ARTICLE
NATURE COMMUNICATIONS | 7:11063 | DOI: 10.1038/ncomms11063 | www.nature.com/naturecommunications 9
WT, but not mutant EB8. The reduced activation of these genes
therefore results from diminished PIC formation and elongating
Pol II.
In contrast to clusters 1 and 2, where basal levels of PIC
formation and Pol II occupancy were observed in ESCs, later
stage activation of cluster 3 genes was associated with high levels
of de novo TFIIB and Pol II recruitment and a potent increase in
H3K27ac in WT EB8, but not mutant EB8 (Fig. 7e). Nevertheless,
H3K4me3 was observed at these promoters in both WT and
mutant ESCs suggesting that even in the absence of PIC
formation they were epigenetically marked for future activation.
Downregulation of genes in cluster 4 during differentiation was
associated with strongly diminished TFIIB, Pol II, H3K27ac and
H3K4me3 in WT EB8 showing diminshed PIC formation that
was less marked in mutant cells. Consequently, Tbp was
redistributed during differentiation of WT ESCs with around
14,000 sites showing preferential or unique occupancy at EB8,
while occupancy of many ES sites was strongly reduced
(Supplementary Fig. 9A). Tbp was enriched at the TSS of 2,086
genes mainly present in clusters 2 and 3 and strongly enriched in
ontology terms associated with brain and the nervous system
consistent with redistribution of Tbp from ES-expressed/plur-
ipotency genes to those involved in neuronal differentiation
(Supplementary Fig. 9B).
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Figure 7 | Taf4 is required for activation of neurogenic genes in differentiating ES cells. (a). Gene expression changes at different stages of
differentiation in Taf4a / compared with WT ES cells. The numbers of genes with altered expression and their fold changes at each stage are indicated.
(b). Global comparison of RNA-seq data in Taf4a / compared to WTat the EB8 stage. The expression of several neurogenic and pluripotency genes are
highlighted. (c). Comparison of the changes in expression of selected marker genes measured by RNA-seq and by RT–qPCR. (d). Kinetics of gene
expression and their alterations during differentiation are represented as a clustered heatmap. The ontology terms associated with the genes in clusters
2–4 that are most affected by Taf4 loss are indicated. (e). Metaproﬁles for the indicated ChIP-seq data sets corresponding to genes in clusters 2–4 are
shown. For TFIIB, H3K4me3 and H3K27ac the proﬁles are centred on the TSS. For Pol II the proﬁles are show over the gene from the transcription start site
(TSS) to the transcription termination site (TTS).
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms11063 ARTICLE
NATURE COMMUNICATIONS | 7:11063 | DOI: 10.1038/ncomms11063 | www.nature.com/naturecommunications 11
In contrast, in Taf4a / EB8, little occupancy of the neuronal
associated WT EB8 sites was observed (Supplementary Fig. 9A).
Instead, Tbp was enriched at EB8 at around 3,000 genes
associated with embryos and a variety of tissues from the
different germ layers (Supplementary Fig. 9C). A smaller group of
around 3,000 sites appeared more strongly occupied in mutant
EB8 that were associated with 400 genes with only poorly
enriched ontology scores.
Together these observations are consistent with the idea that
Tbp was redistributed from ES-expressed/pluripotency to neuro-
genic genes during differentiation of WT ESCs, whereas in
Taf4a / ESCs, Tbp redistribution was diminished, and it
remained associated with ES-expressed genes. Taf4 is therefore
required for de novo PIC formation necessary for activation of
neurogenic genes and for efﬁcient dissociation of the PIC at
pluripotency genes.
Taf4 is essential for contractile cardiomyocyte differentiation.
In the spontaneous differentiation experiments, expression of the
early cardiac markers Nkx2–5 and Anf was reduced and in
accordance with this, we observed a lack of spontaneously con-
tractile cardiomyocytes from the Taf4a / EBs, whereas con-
tractile cardiomyocytes were frequently seen from WT EBs. To
speciﬁcally examine cardiomyocyte differentiation, EBs were
cultured for 5 days in medium containing 20% FCS, before
plating on gelatin-coated plates for a further 9 days.
Spontaneously contracting cardiomyocytes were readily iden-
tiﬁed around 3–5 days after plating of WT EBs, whereas no
contractile activity of mutant cells was observed during the 9-day
period. In agreement with this, Tnnt2 immunostaining revealed
formation of well-deﬁned sarcomeric structures in the differ-
entiated WT cells, whereas such structures were severely reduced,
disorganized and patchy in the Taf4a / cells (Fig. 8a).
Importantly, re-expression of full-length Taf4 restored proper
Tnnt2 expression and formation of organized and functional
sarcomeric structures restoring observable contractile areas
(Fig. 8b, Supplementary Fig. 10A). Taf4 is therefore essential
for differentiation of contractile cardiomyocytes in vitro.
RNA-seq from day 9 differentiated WT and Taf4a / ESCs
identiﬁed 636 upregulated genes and 1,550 downregulated genes
(Fig. 8c,d) associated with muscle contraction, mesoderm
development, cell adhesion and signal transduction
(Supplementary Fig. 10B). Expression of many early and late
cardiomyocyte markers, including those involved in electrophy-
siology of contraction, were strongly reduced in mutant cells
(Fig. 8d and Supplementary Fig. 10B). Nevertheless, as seen
above, pluripotency gene expression was not properly repressed
during cardiomyocyte differentiation. Taf4 is therefore required
for normal activation of the gene expression programme required
for differentiation of functional cardiomyocytes.
Discussion
We deﬁne an essential role of Taf4 in mouse embryogenesis.
Previous inactivation of Tbp or ubiquitous core Tafs led to pre-
implantation or early post-implantation embryonic death35–38.
Due to this early lethality, TAF function at later stages of
mammalian embryogenesis where complex lineage speciﬁcation
and differentiation processes occur is so far unknown. In contrast,
Taf4a / embryos survive until E9.5 and display many
developmental defects. The longer survival of these embryos
may be explained by redundancy with Taf4b that maintains
TFIID integrity and all functions required for early development
and gastrulation, after which the essential role of Taf4 in speciﬁc
developmental processes can be observed. This idea is supported
by the overlapping expression of Taf4a and Taf4b at early stages
of development, the expression of Taf4b in the Taf4a /
embryos and more directly by our observation that Taf4 and
Taf4b are redundant for ESC viability. Moreover, Taf4b / mice
are viable and show defects only at the adult stage7,39. Thus, while
Taf4 can fully replace Taf4b during embryogenesis, Taf4b can
compensate for Taf4 loss in ESCs and at early, but not later stages
of embryogenesis. The observed redundancy may reﬂect the
integration of Taf4b in TFIID in Taf4a / ESCs to maintain its
integrity. However, we cannot exclude other interpretations such
as the presence of Taf4b in an alternative TFIID-like complex
functioning during early development, and a requirement for
Taf4-containing TFIID only at later stages to regulate expression
of a distinct subset of genes that govern further development.
Taf4a / embryos are characterized by several defects.
Embryos displayed an overall atrophy resulting in part from
increased apoptosis, the absence of a large trunk region and a
strongly reduced forebrain domain. However, a striking feature is
the absence of foregut invagination associated with lack of gut
tube formation and aberrant ventral morphogenesis. In WT
embryos, ventral folding morphogenesis achieves gut internaliza-
tion, proper ventral localization of the heart and enclosure of the
fetus in extraembryonic membranes40. Taf4a / embryos are
characterized by incomplete enclosure in the yolk sac,
misplacement of the heart that develops anterior to the head
and a lack of embryo turning. This aspect of the phenotype
strongly resembles embryos lacking Bmp2 that arrest before
turning and show many similar features in particular
misplacement of the heart anterior to the head40. Analysis of
Taf4a / embryos thus conﬁrms the importance of correct
ventral morphogenesis in positioning of head and heart.
Nevertheless, Taf4 is not required for the critical visceral
endoderm expression of Bmp2 that persists in mutant embryos,
suggesting that it may rather be required for the downstream
transcriptional response of the Bmp2 pathway.
While the above phenotypes highlight processes defective in
Taf4a / embryos, others occur almost normally. Taf4 is
dispensible for many patterning events, activation of early neural
and mesodermal makers and the posterior development of the
embryo that, in contrast to the anterior, is almost normal.
Importantly, Pou5f1-expressing PGCs are formed in Taf4a /
embryos although they cannot migrate properly due to the
absence of a developed hindgut. Generation of PGCs involves
complex transcriptional and epigenetic reprogramming events
including reactivation of pluripotency genes as well as changes in
histone and DNA methylation41–43. Taf4 is therefore not required
for this naturally induced reprogramming.
This observation contrasts with a reported role of Taf4 in
maintaining ESC pluripotency and promoting induced pluripo-
tent stem cell reprogramming in vitro. Pijnappel et al.27, reported
that Taf4 overexpression enhanced the ability of Pou5f1, Nanog,
Sox2 and Myc to reprogram human and mouse ﬁbroblasts to
induced pluripotent stem cells in vitro. Furthermore, they
reported that Taf4 or Taf4b short hairpin RNA knockdown
resulted in spontaneous differentiation of ESCs implying that
both are essential for maintaining stemness. They further
proposed Taf4 as an integral component of the pluripotency
network as Pou5f1 and Nanog bind a critical enhancer driving
high Taf4a expression in ESCs. In contrast, Bahat et al.44 used
siRNA knockdown and reported that Taf4b plays a critical role in
maintaining ES cell stemness, whereas Taf4 knockdown had no
effect. Thus, there are conﬂicting data on the role of Taf4 and
Taf4b in maintaining ESC pluripotency, perhaps related to the
techniques used or the efﬁciencies of knockdown achieved.
Our use of genetically modiﬁed mice and ESCs clearly shows
that Taf4 is dispensible for pre-implantation development in vivo
and that Taf4a / ESCs are almost indistinguishable from WT
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ESCs in vitro when grown under pluripotent conditions. As
Taf4b / mice are viable, genetics indicates that neither Taf4
nor Taf4b are essential for pluripotency, but rather are redundant
for this function. Moreover the appearance of PGCs in the
Taf4a / embryos indicates that Taf4b can also replace Taf4 in
this reprogramming event.
Rather than playing a role in ESC pluripotency, our data show
that Taf4 acts during differentiation. Similar to what is seen
in vivo, Taf4a / EBs initiate expression of early markers of all
three germ layers, but Taf4 is essential for the activation of later
stage differentiation genes. Analysis of RA-driven neurogenic
differentiation of Taf4a / ESCs conﬁrmed that expression of
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early-induced genes is affected less than later markers. The
activation kinetics reﬂect somewhat different regulatory mechan-
isms as promoters of early-induced genes show appreciable PIC
formation in the undifferentiated state that is increased during
differentiation, whereas late-induced genes show little PIC
formation in ESCs, their activation being almost completely
dependent on de novo PIC formation. In mutant ESCs reduced
PIC formation is seen at early genes, but is not increased during
differentiation, and de novo PIC formation at later genes is almost
completely abolished. Thus while Taf4b-containing TFIID can
assemble the PIC in ESCs, Taf4 is critical for de novo PIC
formation on later stage neurogenic genes.
The defective neuronal and cardiomyocyte differentiation of
Taf4a / ESCs is reminiscent of the role of Taf3 in endodermal
differentiation of ESCs45. Short hairpin RNA silencing showed
that Taf3 is not required for ESC pluripotency, but plays a
speciﬁc role in endoderm differentiation. Here we show that Taf4
is not required for ESC pluripotency, but plays a more
general role in differentiation of all three germ layers. It is
possible that the overall reduced amounts of TFIID in Taf4a /
ESCs may impact their differentiation. Pijnappel et al.27 (and
Fig. 5a in this study) showed higher levels of Tbp and TAFs in
ESCs compared with ﬁbroblasts and suggested that high TFIID
levels are required for pluripotency. Reduced TFIID would
therefore be expected to affect pluripotency rather than
differentiation. For this reason, we postulate that the defective
differentiation of Taf4a / ESCs and the defects seen in Taf4-
null embryos reﬂect loss of a speciﬁc function of Taf4 rather than
an overall decrease in TFIID.
Bahat et al.44 reported that Taf4 knockdown rendered ESCs
refractory to the effects of RA, whereas we show here incomplete
differentiation of RA-treated Taf4a / ESCs. However,
Bahat et al.44 treated ESCs directly with RA without prior
growth as EBs, an essential feature of the neurogenic
differentiation protocol. Nevertheless, an interesting feature of
differentiating Taf4a / neurons and cardiomyocytes is the
persistent expression of pluripotency genes. Bahat et al.44 showed
that Taf4b, but not Taf4, interacts with Pou5f1. The interactions
of Pou5f1 with the Taf4b-containing TFIID in the Taf4a /
ESCs may promote expression of the pluripotency network to the
detriment of redistribution to differentiation genes thereby
explaining the persistent expression of pluripotency genes in
absence of Taf4.
Methods
Recombinant mice. C57Bl6J mice carrying Taf4a null alleles where exons 11 and
12 have been deleted were previously described16. Taf4a / embryos were
derived from crosses of 6 to 7-week-old Taf4aþ /- animals. Mice were kept in
accordance with institutional guidelines regarding the care and use of laboratory
animals and in accordance with National Animal Care Guidelines (European
Commission directive 86/609/CEE; French decree no.87–848). All procedures were
approved by the French national ethics committee.
Histology and immunohistochemistry. Deciduae were ﬁxed in Bouin’s ﬂuid for
14 h before being dehydrated and embedded in parafﬁn. The embedded decidua
were cut in 5-mm sections and stained with hematoxylin and eosin. Other sections
were used for terminal deoxynucleotidyl nick-end labelling assay using the
ApopTag Peroxidase In Situ.
Apoptosis Detection Kit (Millipore) as described by the manufacturer. To
analyse proliferation, pregnant females were peritoneal injected with BrdU
(50mg kg 1 ﬁnal) and sacriﬁced after 90min. Parafﬁn sections on deciduae
obtained from these litters were boiled in citrate buffer for antigen retrieval and
staining was performed with primary anti-BrdU (555627, BD Biosciences). Pecam
staining on whole-mount embryos and yolk sacs was performed as described46.
Whole-mount in situ hybridization. Mouse embryos were dissected in ice-cold
PBS and ﬁxed O/N in 4% paraformaldehyde (PFA)/PBS. After several washes in
PBS-0.1% Tween-20 (PBT) to eliminate traces of formaldehyde, embryos were
bleached for 1 h in 3% H2O2/PBT and washed 3 5min in PBT before being
digested with Proteinase K (10mgml 1) for 30 s, 1min 30 s or 2min 30 s (E7.5,
E8.5 and E9.5). Digestion was stopped by 5min incubation in 2mgml 1 glycine/
PBT. Embryos were washed again 3 5min in PBT before post-ﬁxing for 20min
in 0.2% glutaraldehyde/4% PFA/PBS. After further washes they were incubated in
prewarmed hybridization buffer and prehybridized for 2 h at 65 C. The buffer was
then replaced with fresh prewarmed hybridization buffer containing the digox-
igenin labelled RNA probes and incubated O/N at 65 C. The next day, embryos
were washed twice in the hybridization buffer at 65 C before treating them with
RNaseA to reduce background. The embryos were then blocked for 2 h in 2%
blocking solution (Roche)/TBS-0.1% Tween-20 (TBST) and incubated O/N in the
same solution containing 1:2,500 anti-digoxigenin antibody (Roche). The
next day the embryos were washed in TBST, before washing them in NTMT buffer
(2 10min) and developing the signal with BM Purple (Roche). Most in situ
hybridisations were performed on three independent WT and mutant embryos.
Generation, culture and differentiation of Taf4a / ES cells. Taf4aþ / mice
were crossed and E3.5 blastocysts were ﬂushed out the uterus and cultured on
mitomycin treated MEF feeders. The ICM outgrowths were trypsinized and pas-
saged on 24-well plates. ES cells were further cultured on inactivated MEF feeders
under standard conditions (DMEM 4.5 g l 1 glucose/Glutamax supplemented with
15% heat inactivated FCS, LIF, nonessential amino acids and b-mercaptoethanol).
Taf4a / ES cells were identiﬁed by PCR as previously described16. For
spontaneous differentiation, ES cells were feeder depleted and allowed to form EBs
in DMEM 4.5 g l 1 glucose/Glutamax supplemented with 10% heat inactivated
FCS, nonessential amino acids and b-mercaptoethanol in non-adherent bacterial
plates. EBs were cultured for a total of 14 days with medium change every other
day. Cells were differentiated by RA into neurons as described33,34. For
differentiation into cardiomyocytes, 4 106 cells were grown as EBs in EB medium
containing 20% heat inactivated FCS and cultured for 5 days. EBs were then
transferred to gelatin-coated plates and cultured for 9 more days. For rescue
experiments, a linearized control plasmid or a plasmid containing recombinant
human or mouse TAF4 complementary DNA (cDNA) was electroporated into
Taf4a / ES cells and selected with puromycin. Resistant clones were further
ampliﬁed and differentiated as described above.
Immunostainings and alkaline phosphatase staining. For immunostaining, cells
were ﬁxed for 30min in 4% paraformaldehyde at room temperature, followed by
incubation in blocking solution (PBS, 0.1% Triton X-100, 5% normal goat serum)
for at least 2 h. Primary antibodies were incubated O/N in blocking solution and
then washed 3 times with PBS, 0.1% Triton X-100 for 10min per step to reduce
unspeciﬁc binding before incubation with secondary antibodies. The Alkaline
Phosphatase Detection Kit (SCR004; Millipore) was used following the manu-
facturers instructions.
Cell growth and cell cycle analysis. To determine growth rates, 5 104 cells
from either WT or mutant ES cells, were plated gelatin-coated six-well plates in
triplicate and counted for 4 consecutive days. For cell cycle analysis, cells were ﬁxed
in 70% ice-cold ethanol O/N, washed with PBS and then stained with propidium
iodide for 4 h. Fluorescence was detected using the BD FACSCalibur ﬂow cyt-
ometer and the obtained data were analysed with the CellQuest software.
Gene expression analyses. Total RNA from ES cells or EBs was isolated using the
GenElute Mammalian Total RNA Miniprep Kit (Sigma-Aldrich). cDNA was
generated using Maxima First Strand cDNA Synthesis Kit for RT-qPCR (Thermo
Scientiﬁc), following the manufacture’s instructions. PCR used the SYBR Green
PCR Master Mix from Qiagen and the LightCycler 480 Real-Time PCR-System
(Roche). Relative expression levels were normalized to GAPDH. RNA-seq analyses
were performed essentially as described47,48. All RT-qPCR experiments were
performed in triplicate. Messanger RNA-seq was performed essentially as
previously described48. Sequence reads mapped to reference genome mm9/NCBI37
using Tophat49. Data normalization and quantiﬁcation of gene expression was
performed using the DESeq 2 Bioconductor package50. Two biological replicates
from two independent WT and Taf4a / ESC lines were analysed. Gene ontology
analyses were performed using the functional annotation clustering function of
DAVID (http://david.abcc.ncifcrf.gov/).
Preparation of ES cell nuclear extracts, IP and immunoblot. ES cells were
resuspended in swelling buffer (25mM Tris pH 7,9, 10mM KCl, 1.5mM MgCl2,
1mM DTT), incubated for 10min on ice, lysed using a dounce homogenizer and
centrifuged. Pelleted nuclei were resuspended in extraction buffer (50mM Tris pH
7,5, 400mM NaCl, 0.5% NP-40, 5% Glycerol and 1Roche complete protease
inhibitor) and proteins were extracted for 2 h at 4 C with rotation. For IP, 500 mg
nuclear extract were pre-cleared for 2 h with 50 ml of protein G sepharose beads,
before addition of with 1 mg of anti-TBP (3G3) antibody O/N at 4 C. The next day,
bound complexes were recovered by incubating the extract with 25 ml protein G
sepharose beads for 2 h at 4 C. Beads containing bound proteins were washed
three times with extraction buffer for 15min per wash and once with the buffer
containing 150mM NaCl before being boiled in in SDS loading buffer for 5min at
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95 C. Bound proteins were analysed by Western blot using the indicated anti-
bodies. A control IP for each extract was performed in parallel using a non-speciﬁc
antibody against glutathione-S transferase (GST). Uncropped western blots are
provided for all immunoblots in Supplementary Figure 11.
Gel ﬁltration. 500 ml of nuclear extracts prepared as described above containing
6mg of protein were injected onto a equilibrated Superose 6 (10/300) column and
run at 0.4mlmin 1. 500 ml fractions were collected and analysed by western blot.
Antibodies. The following antibodies were used: anti-OCT4 (sc-9081; Santa Cruz),
anti-NANOG (RCAB001P; Reprocell), SOX2 (L1D6A2; Cell Signaling), previously
described or recently developed in house antibodies against TBP (3G3), TAF1,
TAF3 (ref. 15), TAF4 (32TA and also sc-136093; Santa Cruz), TAF4B (ref. 16),
TAF5 (1TA), TAF6 (25TA), TAF7 (19TA), TAF12 (22TA), and TAF13 (16TA),
TAF10 (sc-102125; Santa Cruz) and in house 6TA2B11 (ref. 51), anti-Pol II
(sc-9001x; Santa Cruz), anti-Tnnt2 (MS-295-P1; Thermo scientiﬁc). We also used a
polyclonal TAF4B antibody (2057) raised against a peptide corresponding to amino
acids 692–710 of human TAF4B that is 100% conserved in mouse Taf4b. This
antibody also recognizes Taf4 as this region comprises only two amino acid dif-
ferences with Taf4b. The following antibody dilutions were used for immunos-
taining. Pou5f1 and Nanog, 1:100; Sox2, and Taf4, 1:50; Tubb3 and Tnnt2, 1:1,000.
For immunoblots all antibodies were diluted 1:1,000 except polyclonal serum 2057
that was diluted 1:2,000.
Chromatin IP sequencing. Chromatin IP experiments were performed on 0,4%
PFA-ﬁxed chromatin according to standard protocols as previously described15.
Chromatin IP sequencing libraries were prepared and sequenced on an Illumina
Hi-seq2500 as single-end 50-base reads. After sequencing, peak detection was
performed using the MACS software (ref. 52 http://liulab.dfci. harvard.edu/MACS/).
Global clustering, meta analyses and quantitative comparisons were performed using
seqMINER53 and R (http://www.r- project.org/).
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